Search results
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe vaccine sustained protection over a median follow-up of 8.6 months. No serious safety issues were reported, with the most common adverse reactions...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 5 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna's RSV vaccine for older adults approved
Axios· 5 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 5 days ago“The FDA approval of our second product, mRESVIA, builds on the strength and versatility of our mRNA...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 3 days ago"This approval is also the first time an mRNA vaccine has been approved for a disease other than COVID-19," Stéphane Bancel, Moderna's CEO</ ...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 5 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
